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Introduction
Randomised controlled trials investigating the effectiveness 
of spinal manipulative therapy must by definition include 
a control group. The options for the control group include 
a no treatment group, an alternate treatment group, or a 
placebo group. All three have been used in trials of spinal 
manipulative therapy (Bronfort et al 2004, Ferreira et al 
2003) and each has methodological and practical advantages 
and disadvantages.
The use of a no treatment group is potentially simpler and 
cheaper and seems appropriate when the research question 
is to determine the effectiveness of spinal manipulative 
therapy including the specific and non-specific effects. A 
limitation of using a no treatment control group is that the 
specific effects due to spinal manipulative therapy cannot be 
differentiated from placebo effects (Vickers and de Craen 
2000). Withholding treatment may also be an ethical and 
practical consideration when using a no treatment control 
group.
The use of an alternate treatment group (eg exercise) as 
the control group potentially overcomes the difficulties 
associated with withholding treatment. Any additional 
benefit of spinal manipulative therapy over an alternate 
treatment is more likely due to the specific effects of spinal 
manipulative therapy than non-specific effects, including 
placebo, which should be similar between groups (Jones 
et al 1996). The most obvious disadvantage of using an 
alternate treatment control group is that if both treatments 
have similar effects interpretation of the results is very 
difficult. In this case it may not be possible to determine if 
both treatments are equally effective or if neither treatment 
is effective (Tramer et al 1998). Sample sizes needed for 
this design may also be larger as the smallest effects that 
are of interest when treatments are compared will typically 
be smaller than when the treatment is compared to a no 
treatment control (Jones et al 1996).
The use of a placebo group as a control group potentially 
allows for the specific effects of spinal manipulative therapy 
to be separated from the non-specific effects. This design is 
therefore preferred if the study question is to investigate the 
effectiveness of the specific effects of spinal manipulative 
therapy over the non-specific effects. One difficulty with 
this design is that controversy exists as to the mechanism 
by which spinal manipulative therapy works (Bogduk and 
Mercer 2004) and therefore developing a placebo that 
contains the non-specific components but not the specific 
components is potentially problematic. Developing credible 
placebos for spinal manipulative therapy is also potentially 
difficult (Koes 2004).
As part of developing the protocol for a randomised 
controlled trial investigating the effectiveness of spinal 
manipulative therapy in acute low back pain we hoped to 
develop a placebo that was as close as possible to the active 
spinal manipulative therapy, but did not include the specific 
active component. In addition, the placebo needed to appear 
credible. In our trial, active spinal manipulative therapy is 
defined as mobilisation or manipulation procedures whereby 
a physiotherapist applies external forces to the patient which 
aim to produce motion at the intervertebral segments of the 
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lumbar and thoracic spine, the sacroiliac joint, the pelvis, 
and hip. The physiotherapist would adjust the treatment 
according to the clinical presentation of the patient. The 
active spinal manipulative therapy and placebo treatments 
would be delivered two to three times per week for up to 
four weeks. To test if we had been successful in developing 
an appropriate placebo for our trial we asked experts their 
opinion of a variety of potential placebo techniques.
Method
Techniques which may be useful as placebos for spinal 
manipulative therapy were trialled and developed by three 
physiotherapists on colleagues and physiotherapy students. 
The recipients were asked for feedback on whether they 
believed the techniques were active or not and whether 
they would be believable to patients. This feedback was 
used to modify or exclude techniques. Generally the 
placebo techniques involved a therapist placing their hands 
on the patient and producing low forces in directions 
where producing lumbar intervertebral motion appeared 
unlikely. A final list of 10 techniques was developed and 
written descriptions for each technique generated. Four 
of the techniques were called ‘gliders’ and were designed 
to simulate passive accessory movements of the lumbar 
spine, thoracic spine, ilium, and ribs (Maitland 1986). 
The physiotherapist moved the skin sideways across the 
underlying bone rather than producing a downwards force. 
The starting position for the techniques was the same 
as that commonly used, however in the lumbar spine the 
technique was to be performed at least two joints from the 
most symptomatic level. Two of the techniques were called 
‘twisters’ and involved placing the hands on either side of 
the lumbar spine or thoracic spine in the manner commonly 
used to perform a screw manipulation (Maitland 1986). From 
this starting point the hands were moved past each other 
stretching the skin without any downwards pressure. The 
placebo version of rotation mobilisation (Maitland 1986) was 
the ‘log roll’ technique which involved placing the patient 
in side lying and positioning the physiotherapist’s hands 
over the lower ribs and ilium. The pelvis and trunk were 
then rolled together so no or minimal lumbar intervertebral 
motion would occur. A ‘hip twister’ technique involved the 
patient lying supine with the involved leg held at 90 degrees 
of hip and knee flexion by the therapist. The hip was then 
moved passively into internal and external rotation but 
only to half the available range. The final technique, ‘sham 
neural mobilisation’ (Butler 1991) involved a straight leg 
raise to approximately 45 degrees or lower if symptoms 
were elicited. From this point the knee was moved passively 
from 10 to 40 degrees flexion with the ankle relaxed in 
plantarflexion.
The list of ten techniques with descriptions was sent to 
25 experts in the areas of spinal manipulative therapy and 
design of clinical trials from across Australia and New 
Zealand. Both academics and clinicians were included. The 
experts were asked to state whether they considered each 
of the ten techniques to be an appropriate or inappropriate 
placebo for a clinical trial of spinal manipulative therapy. A 
reminder was sent out to those who had not responded after 
two weeks.
Two assessors independently scored all responses as yes or 
no for all techniques. As nearly all respondents who felt a 
technique was not appropriate indicated that they believed 
the technique either contained the active component of 
spinal manipulative therapy or was not credible, the no 
responses were further divided into these two categories. 
Those respondents who did not provide this information 
were emailed for clarification. Therefore for each of the 10 
techniques each expert’s response was scored as appropriate 
placebo, not appropriate (active) or not appropriate (not 
credible). Where the ratings of the two assessors differed 
a third assessor made the final decision or the respondent 
was recontacted for clarification of the response. Agreement 
between raters was assessed using multi-rater kappa.
Results
Sixteen (64%) of the 25 experts responded and their 
responses are shown in Table 1. Multi-rater kappa values 
demonstrated extremely low levels of agreement across the 
experts on all ten possible techniques (kappa = 0.05, 95% 
CI 0.01 to 0.10). The overall agreement between the experts 
was only 37% (chance agreement was 34%). Agreement 
between the experts was also low for the individual 
techniques. For nine of the ten placebos at least one expert 
considered the placebo to include the active component of 
spinal manipulative therapy while at least one other expert 
believed the same placebo was not only not active, but also 
not credible (Table 1). There was no technique that was 
considered an appropriate placebo by more than 50% of the 
respondents (Table 1).
Table 1. Experts’ opinions of proposed placebo techniques (n = 16).
Placebo technique Considered appropriate Considered active Considered not credible
Spine glider thoracic spine 5 4 7
Spine glider lumbar spine 8 7 1
Rib glider 8 2 6
Log roll 8 5 3
Sham neural mobilisation 0 10 6
Hip twister 3 6 7
Hip glider 7 4 5
Hip compression 2 7 7
Skin twist thoracic spine 8 4 4
Skin twist lumbar spine 7 9 0
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Discussion
The results of this study demonstrate the difficulty in 
developing an appropriate placebo for trials of spinal 
manipulative therapy. Even among experts in the field, 
beliefs about what constitutes an appropriate placebo are 
very different. The importance of this finding lies in the 
interpretation of results from placebo-controlled trials of 
spinal manipulative therapy and more particularly the change 
or lack of change in clinical practice as a result of trials 
of spinal manipulative therapy. A recent review of spinal 
manipulative therapy (Assendelft et al 2003) identified six 
placebo-controlled trials of spinal manipulative therapy. Of 
these six trials three used placebos designed to simulate 
spinal manipulative therapy (Ongley et al 1987, Triano et 
al 1995, Waagen et al 1986). Ongley et al (1987) used a 
placebo similar to the sham log roll we described (Ongley 
et al 1987). Based on our results, five (31%) of our experts 
would consider this placebo active, while three (19%) would 
consider it not credible.
Where readers of trials of spinal manipulative therapy do 
not accept the validity of a placebo it is our belief that they 
will tend to ignore the results and no change in clinical 
practice will result. One example of this is when readers 
believe that the placebo contains part or all of the specific 
active components of spinal manipulative therapy (Harman 
2000). In this case negative results will potentially be 
ignored as the reader perceives that both groups contained 
the specific active component and therefore no significant 
difference should be expected between treatments (Paterson 
and Dieppe 2005). If, however, the results of a trial of spinal 
manipulative therapy find a significant difference between 
the placebo and intervention group then this is not such a 
problem. However the reader who believes the placebo is 
active will feel that the effect size underestimates the true 
value.
If the reader of a trial of spinal manipulative therapy believes 
the placebo is not credible then this will also impact on his 
or her interpretation of the results. In this case it is more 
of a problem when the results find a significant difference 
between the placebo and spinal manipulative therapy groups. 
Readers who believe the placebo is not credible will be 
concerned that the improvement found is due to placebo and 
not the active components of spinal manipulative therapy. 
This problem should be easier to deal with as studies can, 
and should, assess the credibility of the placebo using scales 
such as the treatment credibility scale (Borkovec and Nau 
1972).
It is clear from the results of this study that readers of trials of 
spinal manipulative therapy do not agree on what constitutes 
an appropriate placebo. While this situation continues, the 
usefulness of placebo-controlled clinical trials of spinal 
manipulative therapy is diminished and their ability to guide 
and change clinical practice is compromised.
The results of this study beg the question: why do experts 
in the field have such poor agreement on what constitutes 
an appropriate placebo for a trial of spinal manipulative 
therapy? The experts’ comments make it clear that much of 
the lack of agreement is due to different beliefs about what 
are the specific active components of spinal manipulative 
therapy. As an example, one expert who responded stated 
that he believed ‘sensory input’ to be an active constituent of 
spinal manipulative therapy and therefore any placebo that 
involves sensory input to the involved area is potentially 
active and not an appropriate placebo. On the other hand 
another expert felt that ‘reproduction of the patient’s 
symptoms was essential’ for credibility and therefore many 
of our proposed placebos were deemed not believable. 
While the biological basis for spinal manipulative therapy 
remains unclear it appears that controversy will continue 
in interpreting clinical trials of spinal manipulative therapy 
that include a placebo.
A suggested way forward at this point is that studies 
investigating spinal manipulative therapy be very clear 
about the specific aim of the study and use a placebo that 
matches the aim. If the aim is to investigate the overall 
effectiveness in clinical practice of spinal manipulative 
therapy a non treatment group should be employed. If the aim 
is to investigate a specific component of spinal manipulative 
therapy (eg treating the correct level) then a placebo which 
includes all of the other components should be used so the 
only difference is the specific component to be investigated 
(Chiradejnant et al 2002, 2003). If the aim is to investigate 
some specific components of the treatment (eg intervertebral 
motion) but remove some more general components of 
care (eg interaction with a therapist and expectation) then 
a placebo that includes the general components but not the 
specific components of interest should be used. If the aim is 
to evaluate the specific and non-specific effects of treatment 
then a design including both a no treatment control and 
a placebo control will be needed. Following this model 
there should be less disagreement when interpreting the 
results of trials of spinal manipulative therapy. However, 
disagreement over what is the right question to investigate 
may still remain.
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